2-芳基硫杂脯氨酸结构特征的研究

对12种2-芳基硫杂脯氨酸进行了红外光谱和核磁共振谱测定,对其中两个化合物作了质谱测定。结果表明,这类化合物固态时主要以两性离子形式存在;有较强的分子离子峰,是一类较稳定的化合物。它们还存在一对非对映异构体,芳环上的取代基对芳环电子云密度的影响较大,而对四氢噻唑环的影响较小。     

Metabolomic-based investigation of Yinlan alleviating hyperlipidemia by inhibiting blood stasis and phlegm turbidity through the PXR-CYP3A4-ABCB1-FXR pathway

Yinlan lipid regulatory capsule (YL) is a composite traditional Chinese medicine (TCM) new drug to alleviate hyperlipidemia, while its therapeutic mechanism in vivo was not clarified with nontargeted metabolomics investigation. An animal model was established in rats fed a high-fat diet, and their body weights, body mass index (BMI) and blood cholesterol levels were measured. Serum, liver and kidney tissue samples were also extracted for PXR-CYP3A4-ABCB1-FXR signaling pathway research using PCR and UHPLC–MS. The obtained plasma samples were analyzed by UHPLC-Q-TOF-MS metabolomic investigation, which revealed PXR-CYP3A4-related metabolites and changes induced by YL. Finally, the key metabolites were chosen as index components, and their levels in the serum, liver, small intestine and bile were used for simultaneous UHPLC–MS-MS determination. The results indicated that YL was effective in rebalancing blood TG and TC levels (compared to controls). With respect to the PXR-CYP3A4-ABCB1 pathway, as a result of YL’s effect, gene expression or activity of the two targets decreased significantly in both the liver and kidney. The same trend was observed in the serum samples mentioned above. Metabolomics screening and data revealed that 44 metabolites can be regarded as biomarkers related to hyperlipidemia, fatty acids synthesis, and body energy consumption, as well as synthesis, transportation and exertion of cholesterol. YL’s treatment focused on 26 of them, primarily bile acids, indicating that the antihyperlipidemic effect of this drug lies in its inhibitory activity of cholesterol metabolism. Subsequent analysis of those in vivo components revealed that significant increases (compared to the model group) occurred in the blood, liver, small intestine and bile in groups that received medium and high doses of YL (while the low dose was relatively unchanged). Those target components exhibit a close relationship with PXR and/or CYP3A4. The use of YL repressed PXR expression and subsequently decreased CYP3A4 activity. As a result, synthesis of related bile acids increased, while cholesterol levels decreased, consequently leading to the attenuation of hyperlipidemia. This study comprehensively investigated the antihyperlipidemia mechanism of YL based on its repression of PXR-CYP3A4 activity and related metabolite yield, establishing an accurate method for evaluating the therapeutic effect of YL.     

含L－氨基酸结构的手性液晶化合物的合成及其相变行为

合成了９种具Ｌ－氨基酸衍生物结构的介晶化合物（Ｉ－Ⅲ，Ⅳａｂ，Ⅴａ，ｂ，Ⅵａ，ｂ）、４种氨基酸衍生物（Ａ１－４）和６种介晶化合物（Ｍ１－６）．新化合物（Ⅰ－Ⅲ，Ⅳａ，ｂ，Ⅴａ，ｂ，Ⅵａ，ｂ，Ａ４，Ｍ３－６）的化学结构通过ＩＲ、１ＨＮＭＲ和元素分析证实；并用偏光显微观察和ＤＳＣ分析研究了其相变行为，结果表明有８种化合物（Ｍ３－６，Ⅵａ，ｂ，Ⅴｂ，Ⅵｂ）呈现液晶相变。测定了它们的比旋光度。通过Ｘ射线衍射研究了化合物Ⅵｈ１２０～１３０℃和Ⅵｂ１７０～１８０℃的近晶结构，Ⅵｂ显，Ⅵｂ呈。测定了化合物Ⅳｂ的电滞回线，证明其具铁电性。     

双羟基极性键合固定相在氨基酸分析上的应用

我们曾报道了一类新型双羟基键合固定相(GDSB)的合成,研究表明这类固定相具有键合相浓度高,热和化学稳定性好的特点,可用于性质相似的有机化合物的分离。 本文以GDSB为色谱柱填料,含Cu~(2+)离子和烷基磺酸盐的HAc-NaAc缓冲溶液作流动     

各种氨基酸衍生物在Chirasil—Val固定相上的气相色谱分离

本文叙述氨基酸及其对映体的全氟酰基烷基脂(O-异丙基、-异丁基、-正丁基;N(O,S)-三氟乙酰基,TFA、-七氟丁酰基,HFB)在Chirasil-Val上的洗脱特性。随烷基取代增大,保留时间增加;用HFB代替TFA,对映体的分离因子降低。此外,DL-氨基酸与另丁醇衍生,生成的对映及非对映衍生物在Chirasil-Val上可拆分成四个色谱峰。     

Homogeneous chemiluminescence system in neutral and near neutral aqueous solution with ClO2 as oxidant and its analytical application

Using ClO₂ as chemiluminescence (CL) oxidant, a novel homogeneous CL system in neutral and near neutral aqueous solution is proposed in this paper. ClO₂ could oxidize sulfite in pH 5.0–8.5 acetate buffer to produce CL emission, and pipemidic acid could sensitize the CL system. The ClO₂–SO₃²⁻–pipemidic acid reaction was used as a model CL system and explored the possibility of highly active and eco-friendly ClO₂ being used as CL oxidant in neutral and near neutral aqueous solution. Combined with flow-injection analysis, the proposed CL system was applied to the automated dissolution testing of pipemidic acid tablet. Compared with the common strong acidic or strong basic CL system, this proposed CL owns its advantages.     

Evaporation behavior of water from aqueous dispersions of multihollow particles prepared by the stepwise alkali/acid method

In order to clarify the formation mechanism of multihollow structures inside styrene–methacrylic acid copolymer particles prepared by the stepwise alkali/acid method, which we proposed in 1990, the evaporation behavior of water from aqueous dispersions of the original carboxylated particles and those after the alkali treatment and the stepwise alkali/acid treatments was examined. It is concluded that the particle after the alkali treatment had a number of small water pools inside. Received: 22 February 2001 Accepted: 20 June 2001     

一种含氟丙烯酸树脂的制备及其表面疏水性

在聚合反应的后期阶段,向体系中引入含氟丙烯酸酯单体全氟辛基-(N-乙基-N-丙烯酸乙酯基)磺酰胺(QG-F814)共聚改性的方法制备了一种含氟丙烯酸树脂.接触角测定表明,该树脂具有良好的疏水性能.热重分析表明,该树脂在改性前后的耐热稳定性差别不大.     

Synthesis of novel organoselenium as catalyst for Baeyer-Villiger oxidation with 30% H2O2

A novel diselenide was synthesized in good yield via only four steps from phenol, and was employed as the catalyst for the Baeyer-Villiger oxidation with 30% H₂O₂ to obtain lactones in good yields.     

从蓖麻油制取10-羟基癸酸的研究

本文报道了从蓖麻油制取10-羟基癸酸的研究,发现了从蓖麻油制取10-羟基癸酸的新的工艺路线和最佳的工艺条件,用氢氧化钠用量、2-辛醇量、反应时间和反应温度四因子三水平L_9(3~4)进行了正交试验,发现最佳工艺条件是:氢氧化钠(g)/蓖麻油(g):1.25:2-辛醇量(g)/蓖麻油(g):2:反应时间:6h;反应温度:180℃。在这一新的工艺路线和最佳工艺条件下,10-羟基癸酸产率可达75％。